Recce Pharmaceuticals Ltd (RCE.AX)
AUD 0.29
(-3.33%)
AUD 0.29
(-3.33%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -17.66 Million AUD | -35.06% |
| 2023 | -13.07 Million AUD | -19.03% |
| 2022 | -10.98 Million AUD | 18.7% |
| 2021 | -13.51 Million AUD | -213.05% |
| 2020 | -4.31 Million AUD | -54.77% |
| 2019 | -2.78 Million AUD | -66.59% |
| 2018 | -1.67 Million AUD | 44.66% |
| 2017 | -3.02 Million AUD | 37.49% |
| 2016 | -4.84 Million AUD | -975.24% |
| 2015 | -450.16 Thousand AUD | -65.25% |
| 2014 | -272.41 Thousand AUD | 6.85% |
| 2013 | -292.46 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | -17.66 Million AUD | -35.06% |
| 2024 Q2 | -7.46 Million AUD | 0.0% |
| 2024 Q4 | -10.19 Million AUD | 0.0% |
| 2023 Q2 | -9.22 Million AUD | 0.0% |
| 2023 Q4 | -3.85 Million AUD | 0.0% |
| 2023 FY | -13.07 Million AUD | -19.03% |
| 2022 Q4 | -6 Million AUD | 0.0% |
| 2022 FY | -10.98 Million AUD | 18.7% |
| 2022 Q2 | -4.98 Million AUD | 0.0% |
| 2021 Q2 | -10.19 Million AUD | 0.0% |
| 2021 FY | -13.51 Million AUD | -213.05% |
| 2021 Q4 | -3.32 Million AUD | 0.0% |
| 2020 FY | -4.31 Million AUD | -54.77% |
| 2020 Q4 | -2.98 Million AUD | 0.0% |
| 2020 Q2 | -1.33 Million AUD | 0.0% |
| 2019 FY | -2.78 Million AUD | -66.59% |
| 2019 Q2 | -1.06 Million AUD | 0.0% |
| 2019 Q4 | -1.72 Million AUD | 0.0% |
| 2018 Q2 | -1.04 Million AUD | 0.0% |
| 2018 FY | -1.67 Million AUD | 44.66% |
| 2018 Q4 | -630.21 Thousand AUD | 0.0% |
| 2017 Q4 | -1.69 Million AUD | 0.0% |
| 2017 FY | -3.02 Million AUD | 37.49% |
| 2017 Q2 | -1.33 Million AUD | 0.0% |
| 2016 FY | -4.84 Million AUD | -975.24% |
| 2016 Q4 | -884.1 Thousand AUD | 0.0% |
| 2016 Q2 | -3.95 Million AUD | 0.0% |
| 2015 Q3 | - AUD | 100.0% |
| 2015 FY | -450.16 Thousand AUD | -65.25% |
| 2015 Q2 | -185.03 Thousand AUD | 0.0% |
| 2015 Q4 | -265.12 Thousand AUD | 0.0% |
| 2014 FY | -272.41 Thousand AUD | 6.85% |
| 2013 FY | -292.46 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| AdAlta Limited | -5.38 Million AUD | -228.207% |
| Acrux Limited | -5.8 Million AUD | -204.512% |
| Botanix Pharmaceuticals Limited | -13.86 Million AUD | -27.34% |
| BTC Health Limited | 1.05 Million AUD | 1773.641% |
| Chimeric Therapeutics Limited | -12.52 Million AUD | -40.957% |
| Clarity Pharmaceuticals Ltd | -42.32 Million AUD | 58.271% |
| Clinuvel Pharmaceuticals Limited | 35.63 Million AUD | 149.561% |
| Biome Australia Limited | -1.67 Million AUD | -957.46% |
| Hexima Limited | -933.87 Thousand AUD | -1791.233% |
| Immutep Limited | -39.89 Million AUD | 55.731% |
| Memphasys Limited | -4.44 Million AUD | -297.605% |
| Neuren Pharmaceuticals Limited | 157.08 Million AUD | 111.244% |
| Noxopharm Limited | -3.57 Million AUD | -393.604% |
| Prescient Therapeutics Limited | -8.23 Million AUD | -114.392% |
| Race Oncology Limited | -13.81 Million AUD | -27.804% |
| Radiopharm Theranostics Limited | -47.94 Million AUD | 63.166% |
| Starpharma Holdings Limited | -8.16 Million AUD | -116.31% |
| Tissue Repair Ltd | -4.13 Million AUD | -326.807% |
| Biotron Limited | -3.43 Million AUD | -413.941% |
| Alterity Therapeutics Limited | -19.12 Million AUD | 7.644% |
| CSL Limited | 2.64 Billion AUD | 100.668% |
| EZZ Life Science Holdings Limited | 6.96 Million AUD | 353.597% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -1117.007% |
| Bio-Gene Technology Limited | -2.4 Million AUD | -633.101% |
| Zelira Therapeutics Limited | -36.56 Million AUD | 51.703% |
| Patrys Limited | -3.53 Million AUD | -399.038% |
| Orthocell Limited | -7.18 Million AUD | -145.952% |
| Imugene Limited | -149.68 Million AUD | 88.2% |
| PYC Therapeutics Limited | -37.72 Million AUD | 53.184% |
| Proteomics International Laboratories Limited | -6.37 Million AUD | -176.994% |
| Cynata Therapeutics Limited | -9.74 Million AUD | -81.244% |
| Arovella Therapeutics Limited | -8.74 Million AUD | -101.94% |
| Nanollose Limited | -1.15 Million AUD | -1427.099% |
| Invex Therapeutics Ltd | -1.64 Million AUD | -975.747% |
| NeuroScientific Biopharmaceuticals Limited | 324.21 Thousand AUD | 5547.615% |
| Amplia Therapeutics Limited | -4.5 Million AUD | -292.182% |
| Island Pharmaceuticals Limited | -2.86 Million AUD | -516.611% |
| Nyrada Inc. | -1.38 Million AUD | -1174.085% |
| Telix Pharmaceuticals Limited | 5.21 Million AUD | 438.931% |
| Dimerix Limited | -17.07 Million AUD | -3.436% |
| PharmAust Limited | -9.03 Million AUD | -95.538% |
| AnteoTech Limited | -8.88 Million AUD | -98.882% |
| Paradigm Biopharmaceuticals Limited | -58.65 Million AUD | 69.888% |
| Avecho Biotechnology Limited | -3.43 Million AUD | -413.936% |
| Actinogen Medical Limited | -13.04 Million AUD | -35.398% |
| Immuron Limited | -6.93 Million AUD | -154.603% |
| Argenica Therapeutics Limited | -5.47 Million AUD | -222.324% |